Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory and Relapsed T Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03929107
What this trial is testing

Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma.

Who this might be right for
B Cell Lymphoma
Wenbin Qian 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279584
What this trial is testing

Golidocitinib Combined With GemOx in RR PTCL

Who this might be right for
Peripheral T-cell Lymphomas (PTCL)
Ruijin Hospital 31
Testing effectiveness (Phase 2)Looking for participantsNCT05948033
What this trial is testing

CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

Who this might be right for
Lymphoma
Chinese PLA General Hospital 30
Not applicableNot Yet RecruitingNCT07713511
What this trial is testing

INfections in Patients Treated With CAR-T

Who this might be right for
Relapsed Multiple MyelomaRefractory Multiple MyelomaB-Cell Non-Hodgkin Lymphoma+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 290
Testing effectiveness (Phase 2)Ended earlyNCT01419795
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00058019
What this trial is testing

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+3 more
National Cancer Institute (NCI) 51
Early research (Phase 1)Looking for participantsNCT05659628
What this trial is testing

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Ningbo No. 1 Hospital 24
Not applicableUnknownNCT06049381
What this trial is testing

Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research

Who this might be right for
Relapsed Non-Hodgkin Lymphoma
Ruijin Hospital 22
Very early researchLooking for participantsNCT07312630
What this trial is testing

Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Acute Lymphoblastic Leukemia (ALL), Adult
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 19
Early research (Phase 1)Looking for participantsNCT07350863
What this trial is testing

U69-CART-Cells For R/R T-ALL

Who this might be right for
Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 12
Testing effectiveness (Phase 2)Looking for participantsNCT06880913
What this trial is testing

Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06378190
What this trial is testing

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Who this might be right for
Refractory B-Cell LymphomaB-cell Lymphoma Recurrent
Instituto de Investigación Biomédica de Salamanca 27
Not applicableLooking for participantsNCT06541327
What this trial is testing

Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

Who this might be right for
Lymphoma, Non-Hodgkin
Ruijin Hospital 1,000
Early research (Phase 1)Looking for participantsNCT05836896
What this trial is testing

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies

Who this might be right for
NeoplasmsRelapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)+2 more
Technische Universität Dresden 16
Testing effectiveness (Phase 2)Looking for participantsNCT07319676
What this trial is testing

Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

Who this might be right for
B-cell Lymphoma Refractory
National University Hospital, Singapore 30
Testing effectiveness (Phase 2)Study completedNCT00006020
What this trial is testing

S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 35
Testing effectiveness (Phase 2)WithdrawnNCT05312476
What this trial is testing

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
The First Affiliated Hospital of Soochow University
Early research (Phase 1)Study completedNCT00406757
What this trial is testing

Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma

Who this might be right for
Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic
GlaxoSmithKline 13
Testing effectiveness (Phase 2)Ended earlyNCT01483690
What this trial is testing

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Who this might be right for
Acute Lymphoblastic LeukemiaPrecursor B-Cell Lymphoblastic LeukemiaPrecursor T-Cell Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 23
Testing effectiveness (Phase 2)Ended earlyNCT04109482
What this trial is testing

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mustang Bio 3
Next Page